Related Experiment Video

Updated: Jul 8, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Management of growth retardation in juvenile idiopathic arthritis

Dominique Simon1

  • 1Service d'Endocrinologie Pédiatrique, Hôpital Robert Debré, Paris, France. Dominique.simon@rdb.aphp.fr

Hormone Research
|February 7, 2008
PubMed

Insights

Early growth hormone (GH) therapy can help children with juvenile idiopathic arthritis (JIA) maintain normal growth. Careful monitoring is crucial for preserving long-term growth potential during disease progression.

Area of Science:

  • Pediatric Rheumatology
  • Endocrinology
  • Growth Disorders

Background:

  • Juvenile idiopathic arthritis (JIA) often causes growth retardation due to inflammation and glucocorticoid therapy.
  • While TNF-alpha antagonists show some promise, etanercept has limited efficacy in systemic JIA.
  • Growth hormone (GH) has been used to treat JIA-related growth retardation, but catch-up growth varies with disease severity and steroid dosage.

Purpose of the Study:

  • To evaluate the efficacy of early growth hormone (GH) treatment in maintaining normal growth in children with JIA.
  • To highlight the importance of monitoring growth in JIA patients.

Main Methods:

  • Observational study analyzing growth patterns in JIA patients undergoing treatment.
  • Assessment of growth velocity and height preservation in relation to GH therapy, inflammation, and glucocorticoid use.

Main Results:

  • Early institution of GH treatment has demonstrated the ability to maintain normal growth velocity in children with JIA.
  • GH treatment can normalize growth and prevent severe height loss, though outcomes depend on disease severity and steroid doses.

Conclusions:

  • Early GH therapy is a valuable tool for preserving growth in JIA patients before severe growth delay occurs.
  • Continuous monitoring of growth is essential for children with JIA.
  • GH therapy holds potential for preserving long-term growth even during disease progression.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...